dexamethasone cyclodextrin nanoparticle ophthalmic suspension (OCS-01) - Oculis
LEOPARD: Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Uveitis Related and Post Surgical Macular Edema (clinicaltrials.gov) - May 27, 2025 - P2 | N=28 | Active, not recruiting | Sponsor: Quan Dong Nguyen | Trial completion date: Sep 2025 ➔ Sep 2026 | Trial primary completion date: Jun 2025 ➔ Jun 2026 
Trial completion date • Trial primary completion date • Macular Edema • Ocular Inflammation • Ophthalmology • Uveitis
http://clinicaltrials.gov/ct2/show/NCT05608837
 
May 27, 2025
 
Prev Next